Выпуск №2-3 за 2011 год
Вице-Президент по исследованиям и разработкам "IsoRay Medikal ", США
Существует прямая, обусловленная физиологически, связь между абляцией опухолевой ткани и последующим иммунологическим...
Выпуск №4 за 2011 год
Review of clinical and experimental
data on medications, nutritional
and non nutritional substances, that
able to slow down cancerogenesis
in prostate. Review and classification
of medications and...
Выпуск №4 за 2011 год
In recent time interest for new methods
of malignant tumors is growing,
one of the most promising is immune
therapy. The main reason of such interest
is caused by the fact that nearly
one third of...
Выпуск №4 за 2011 год
One of the biggest problems in the diagnosis
of prostate cancer (PCa), which
distinguishes it from many other solid
tumors, is the difficulty of visualization
of the tumor process by using modern...
Выпуск №4 за 2011 год
In this review article we have analyzed
the results of major contemporary
investigations that concern
kidney cancer biomarkers searching.
Thanks to the new scientific achievements
in fields of...
Выпуск №1 за 2012 год
Prostate gland malignant tumors –
actual problem of modern oncology.
Radical prostatectomy (RPE)
is a most efficient treatment option
with patients’ high survival and
quality of life rates...
Выпуск №2 за 2013 год
Patient with low-risk prostate cancer
who previously had to choose between
radical treatment and active surveillance
may have a new treatment. The study of
prostate cancer, technological advances
in...
Выпуск №2 за 2013 год
Even when a fact is considered, that a
standard method of the treatment of the
localized prostate cancer for cT1a-T2b
patients is traditional open radical
prostatectomy, this operation is often...
Выпуск №2 за 2013 год
This article is a review of the last randomized
trials, devoted to the assessment and
standardization of the neoadjuvant and
adjuvant androgen deprivation models in
combination with the external...
Выпуск №3 за 2012 год
Ultrastructural studies have shown a wide morphological diversity of neuroendocrine cells (NEC), which is correlated with a large number of known secreted into the blood substances, including...
Выпуск №3 за 2012 год
At present time the issue of early detection of prostate cancer (CaP) becomes more and more actual. CaP has a very high morbidity and mortality rate increase temp, which is connected with disease...
Выпуск №4 за 2012 год
Introduction...
Выпуск №4 за 2012 год
Introduction: Watertightness of UVA is
still most challenging stage of LRP. Fail to
provide full watertightness may provide
urinary leakage, prolonged urethral
catheterization, long...
Выпуск №1 за 2013 год
Increasing the dose proved to be effective
(fewer biochemical recurrence) in external
beam radiotherapy for prostate cancer.
Underway attempts to extrapolate this
relationship to permanent (low-dose...
Выпуск №1 за 2012 год
Hormone therapy (HT) for prostate cancer (PCa) is the first line drug therapy for metastatic prostate cancer. The time between the onset of hormonal medications and the development of hormone-...
Выпуск №1 за 2012 год
Prostate cancer (PCa) – one of the most common diseases among the male population of the world, providing a major impact on world health and economy. It is believed that the disease within...
Выпуск №1 за 2010 год
An open comparative study was performed at the Research Institute of Urology to examine sensibility and safety of technetium-labeled zoledronic acid drug Rezoscan,99mTc in patients with prostate...
Выпуск №1 за 2010 год
In despite of achievements in different types of urine derivation, the estimation of life' quality in patients underwent of such type of operative treatment still be not only the medical problem...
Выпуск №4 за 2010 год
Chronic pyelonephritis is one of the most common diseases complicating numerous urologic pathologies or occurring as an independent pathology. Chronic pyelonephritis due to insufficient and often non...
Выпуск №1 за 2011 год
At present time radical prostatectomy (RPE) remains one of the most common option of prostate cancer (PCa) surgical treatment. Oncologic specific survival rate is the main criteria of surgical...
Выпуск №1 за 2011 год
Brief definition of immunohistochemical assay was given in this article. The role of immunohistochemical assay in prostate cancer diagnostics was shown. Immunohistochemical markers were...
Выпуск №1 за 2011 год
At present time the challenge of prostate cancer early detection becomes more and more vital due to prostate cancer (PCa) is one of the most common malignant tumors in males. Development and...
Выпуск №3 за 2010 год
Not only clinical efficiency but costeffectiveness
is to be considered in a
choice of treatment option, particularly
in oncologic patients. Oncologic
patients treatment needs large...
Выпуск №3 за 2010 год
Most frequent prostate cancer radiation
therapy complications are radiation,
prostatitis cystitis and proctitis,
with dysuria of different degree of
manifestating. It can be also...